Information Provided By: 
Fly News Breaks for April 28, 2017
SYK, ZBH
Apr 28, 2017 | 08:11 EDT
As noted earlier, Wells Fargo downgraded Zimmer Biomet to Market Perform from Outperform. The firm says that the company's performance has been "inconsistent" since its acquisition of Biomet, while channel checks indicate that its supply issues are not improving. Additionally, the firm thinks that Zimmer faces a threat over the medium and long-term from Stryker's (SYK) Mako total knee application.
News For ZBH;SYK From the Last 2 Days
